A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)Research in context

A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)Research in context

Summary: Background: To evaluate the efficacy and safety of toripalimab combined with neoadjuvant chemoradiotherapy (NCRT) for locally advanced esophageal squamous cell carcinoma (ESCC). Methods: In this single arm, phase II trial, 44 ESCC patients were enrolled from December 2019 to July 2021 at S...

Full description

Bibliographic Details
Main Authors: Rui Chen, Qianwen Liu, Qiaoqiao Li, Yujia Zhu, Lei Zhao, Shiliang Liu, Baoqing Chen, Mengzhong Liu, Yonghong Hu, Ting Lin, Jibin Li, Jiyang Chen, Yingxin Lv, Jianhua Fu, Mian Xi, Hong Yang
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:EClinicalMedicine
Subjects:
Esophageal squamous cell carcinoma
Toripalimab
Neoadjuvant chemoradiotherapy
Pathological complete response
Safety
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702300295X

Internet

http://www.sciencedirect.com/science/article/pii/S258953702300295X

Similar Items